🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yi Ban

New York University

ORCID: 0000-0002-7644-9686
Computer ScienceMedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis”.

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

Nature Communications(2021)10.1038/s41467-021-27559-z
N/A
4.7DataRank · unranked
314 citations

Mirela Berisa, Diamile A. Tavarez, Zhuoning Li, Matthew M. Miele, Yang Bai +10 more

Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer

eLife(2023)10.7554/elife.89486
N/A
0.542DataRank · unranked
9 citations

Yue Zou, Y. Liu, S. S. Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

Cancer Research(2023)10.1158/0008-5472.can-23-2729
N/A
0DataRank · unranked
106 citations

Hsin‐Yi Huang, Ziyan Lin, Michela Ranieri, Shuai Li, Soumyadip Sahu +21 more

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.28.546927
N/A
0DataRank · unranked
2 citations

Yue Zou, Y. Liu, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2023)10.7554/elife.89486.1
N/A
0DataRank · unranked
1 citations

Yue Zou, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng, Yuliang Cao +3 more

Data from Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis

(2023)10.1158/0008-5472.c.6511941.v1
N/A
0DataRank · unranked
0 citations

Yi Ban, Michael J. Crowley, Sharrell B. Lee, Divya Ramchandani, Wei Du +9 more

Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade

Research Square(2023)10.21203/rs.3.rs-3356477/v1
N/A
0DataRank · unranked
0 citations

Yi Ban, Diamile A. Tavarez, Liron Yoffe, Enrique Podaza, Yongfeng He +11 more

Reviewer #3 (Public Review): Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2023)10.7554/elife.89486.1.sa0
N/A
0DataRank · unranked
0 citations

Yue Zou, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng, Yuliang Cao +3 more

Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy

Nature Immunology(2024)10.1038/s41590-024-01963-1
N/A
0DataRank · unranked
43 citations

Yi Ban, Diamile A. Tavarez, Liron Yoffe, Enrique Podaza, Yongfeng He +11 more

Author response: Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2024)10.7554/elife.89486.2.sa0
N/A
0DataRank · unranked
0 citations

Yue Zou, Y. Liu, Sharrell Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

965 Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway to generate TCF1+ progenitor CD8 T cells to improve efficacy of PD-1 checkpoint blockade

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0965
N/A
0DataRank · unranked
1 citations

Yi Ban, Diamile A. Tavarez, Michael J. Crowley, Liron Yoffe, Mitchell Martin +7 more